PacBridge Capital Partners (HK) Limited, a Hong Kong-based investment firm, has committed to a C$12 million ($9.46 million) facility to fund Contextual Genomics Inc., a Canadian cancer genomics company.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
